Healthcare

That scale raises a practical question for investors in Australian shares: how could one respiratory care specialist influence momentum in a sector that has at times weighed on the broader benchmark? The answer involves consumables, currency and the market's appetite for dependableEarningsgrowth.

Cochlear designs and sells implantable hearing solutions. Its core product is the cochlear implant, which bypasses damaged parts of the inner ear for people with severe to profound hearing loss. It also sells sound processor upgrades to existing recipients through its Services business, and …

CSL is a global biotechnology company headquartered in Melbourne, operating through three businesses:

Adherium Limited (ASX:ADR) is a digital health company focused on connected respiratory medical devices and remote patient monitoring solutions. The company developed the US FDA-cleared Hailie® Smartinhaler® platform, which enables clinicians, healthcare providers and patients to monitor respiratory medication usage and adherence. During FY26, …

• BCAL Diagnostics Limited (ASX:BDX) has started introducing Avantect Multi-Cancer, a blood-based early cancer detection test, to Australia.

• Prescient Therapeutics Limited (ASX:PTX) has completed aCapitalraising of about $6 million, combining a share purchase plan (SPP) for existing shareholders with a follow-on shortfallPlacementto sophisticated and professional investors.

• Dimerix Limited (ASX:DXB) has completed the initial drawdown under its A$34 million non-dilutive funding facility, receiving gross proceeds of approximately A$17 million.